miRNA-148a regulates the expression of the estrogen receptor through DNMT1-mediated DNA methylation in breast cancer cells
Authors:
Open Access
- 23 August 2017
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (4) , 4736-4740
Abstract
Breast cancer remains the most prevalent cancer among women worldwide. The expression of estrogen receptor‑α (ER‑α) is an important marker for prognosis. ER‑α status may be positive or negative in breast cancer cells, although the cause of negative or positive status is not yet fully characterized. In the present study, the expression of ER‑α and miRNA‑148a was assessed in two breast cancer cell lines, HCC1937 and MCF7. An association between ER‑α and miRNA‑148a expression was identified. It was then demonstrated that DNA methyltransferase 1 (DNMT1) is a target of miRNA‑148a, which may suppress the expression of ER‑α via DNA methylation. Finally, an miRNA‑148a mimic or inhibitor was transfected into MCF7 cells; the miRNA‑148a mimic increased ER‑α expression whereas the miRNA‑148a inhibitor decreased ER‑α expression. In conclusion, it was identified that miRNA‑148a regulates ER‑α expression through DNMT1‑mediated DNA methylation in breast cancer cells. This may represent a potential miRNA‑based strategy to modulate the expression of ER‑α and provide a novel perspective for investigating the role of miRNAs in treating breast cancer.Keywords
This publication has 27 references indexed in Scilit:
- The MicroRNA-148/152 Family: Multi-faceted PlayersMolecular Cancer, 2013
- A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1Journal of Molecular Cell Biology, 2012
- DNA methylation signatures for breast cancer classification and prognosisGenome Medicine, 2012
- microRNA-152 Mediates DNMT1-Regulated DNA Methylation in the Estrogen Receptor α GenePLOS ONE, 2012
- Down-Regulated MicroRNA-152 Induces Aberrant DNA Methylation in Hepatitis B Virus–Related Hepatocellular Carcinoma by Targeting DNA Methyltransferase 1Hepatology, 2010
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast CancerClinical Breast Cancer, 2009
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Specific Inhibition of DNMT1 by Antisense Oligonucleotides Induces Re-expression of Estrogen Receptor a (ER) in ER-negative Human Breast Cancer Cell LinesCancer Biology & Therapy, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Targeted mutation of the DNA methyltransferase gene results in embryonic lethalityCell, 1992